Professor Paulo E. Stanga

Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital, Professor of Ophthalmology and Retinal Regeneration for the University of Manchester, UK

Professor Stanga specializes in vitreoretinal disorders that require either medical or surgical treatment. He is well known for his work in developing new outpatient and surgical therapies and technologies including macular translocation surgery and Pascal® laser photocoagulation, and he is the Manchester Primary Investigator for the Argus II (Bionic Eye) 10-center international trial on the epiretinal electronic implant for blindness in Retinitis Pigmentosa, having operated upon and presented at international meetings the results of the first patients in the trial to achieve word-reading, colour perception or face detection capability with the implant. Prof. Stanga has now set-up a Manchester-only Pilot Study of the Argus II system in patients with the Dry form of Age-Related Macular Degeneration and is the Principal Investigator for this study.

 

He has published extensively with peer reviewed papers and book chapters covering a wide range of retina and vitreous related topics, including many on Swept Source OCT, and he has lectured around the world.

 

We are delighted that Professor Stanga is bringing his expertise to the scientific program committee and will be sharing his clinical and research findings during presentations at the conference.